Overview of the 2022 WHO classification of thyroid neoplasms

ZW Baloch, SL Asa, JA Barletta, RA Ghossein… - Endocrine …, 2022 - Springer
This review summarizes the changes in the 5th edition of the WHO Classification of
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …

[HTML][HTML] Update from the 2022 World Health Organization classification of thyroid tumors: a standardized diagnostic approach

CK Jung, A Bychkov, K Kakudo - Endocrinology and …, 2022 - synapse.koreamed.org
The fifth edition of the World Health Organization (WHO) histologic classification of thyroid
neoplasms released in 2022 includes newly recognized tumor types, subtypes, and a …

Management of thyroid nodules

EK Alexander, GM Doherty, JA Barletta - The Lancet Diabetes & …, 2022 - thelancet.com
In the past 30 years, there has been a substantial rise in the detection of thyroid nodules.
Largely asymptomatic, thyroid nodules are most often incidental findings that typically pose …

[HTML][HTML] The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading

CC Juhlin, O Mete, ZW Baloch - Endocrine-related cancer, 2023 - erc.bioscientifica.com
The 5th edition of the Classification of Endocrine and Neuroendocrine Tumors has been
released by the World Health Organization (WHO). This timely publication integrates several …

Overview of the 2022 WHO classification of familial endocrine tumor syndromes

V Nosé, A Gill, JMC Teijeiro, A Perren, L Erickson - Endocrine pathology, 2022 - Springer
This review of the familial tumor syndromes involving the endocrine organs is focused on
discussing the main updates on the upcoming fifth edition of the WHO Classification of …

Update from the 5th edition of the World Health Organization classification of head and neck tumors: familial tumor syndromes

V Nosé, AJ Lazar - Head and neck pathology, 2022 - Springer
The initiative of the 5th edition of the WHO classification of the Head and Neck Tumours
establishing a new section dedicated to familial/heritable tumor syndromes with tumors and …

Combining molecular testing and the Bethesda category III: VI ratio for thyroid fine‐needle aspirates: a quality‐assurance metric for evaluating diagnostic performance …

HN Gokozan, TL Dilcher, SA Alperstein… - Cancer …, 2022 - Wiley Online Library
Background Molecular testing (MT) of thyroid fine‐needle aspiration (FNA)‐derived genetic
material is commonly used to assess malignancy risk for indeterminate cases. The Bethesda …

[HTML][HTML] Cribriform morular thyroid carcinoma–ultimobranchial pouch-related? Deep molecular insights of a unique case

MS Dettmer, S Hürlimann, L Scheuble, E Vassella… - Endocrine …, 2023 - Springer
A 44-year-old female patient with a familial adenomatous polyposis (FAP) was diagnosed
with a cribriform morular thyroid carcinoma (CMTC). We observed within the very necrotic …

The Classic, the trendy, and the refashioned: a primer for pathologists on what is new in familial endocrine tumor syndromes

E Ababneh, V Nosé - Advances in Anatomic Pathology, 2023 - journals.lww.com
Familial endocrine tumor syndromes are continuously expanding owing to the growing role
of genetic testing in routine clinical practice. Pathologists are usually the first on the clinical …

[HTML][HTML] Cribriform morular thyroid carcinoma: a case report with pathological, immunohistochemical, and molecular findings suggesting an origin from follicular cells …

A Echegoyen-Silanes, JJ Pineda-Arribas… - Virchows Archiv, 2023 - Springer
Cribriform morular thyroid carcinoma (CMTC) is a rare malignant thyroid tumor with a
peculiar growth pattern secondary to permanent activation of the WNT/β-catenin pathway …